Nathan H. Fowler, MD and Massimo Federico, MD
In this episode, “Toward Personalized Therapy for FL”, Nathan H. Fowler, MD and Massimo Federico, MD identify some aspects where a more individualized approach for patients with FL (follicular lymphoma) might be beneficial.
Recent advances suggest that a one-size-fits-all approach may no longer be optimal. One question is whether physicians should continue to apply the same maintenance approach for all patients responding to first line therapy. Another is whether risk for transformation in the rituximab era could potentially inform treatment. Standard frontline chemotherapy is also being challenged.